dana–farber cancer institute

Adding GM-CSF to Ipilimumab Extends Survival in Metastatic Melanoma

Adding GM-CSF to ipilimumab extends survival in metastatic melanoma

Filed under: willard drug treatment center

"We are waiting for the data to mature in ongoing studies examining the relative efficacy of 3 mg/kg and 10 mg/kg dosing," said Dr. Hodi, director of the melanoma center at Dana-Farber Cancer Institute in… Continue reading

Texas Drug Treatment Centers

Many cancer patients mistakenly believe chemotherapies will cure them, new

Filed under: Texas Drug Treatment Centers

They found that 69 percent of patients with metastatic lung cancer and 81 percent of patients with advanced colorectal cancer reported that their chemotherapy might be curative, despite the fact that the drugs… Continue reading